Key Changes Approved

  • The Board of Directors approved the changes through circulation on August 27, 2026
  • Changes due to unavoidable circumstances, administrative and scheduling constraints
  • Follows previous intimation dated 31st July, 2026

Revised Schedule Details

1. Annual General Meeting

  • Event: 38th Annual General Meeting for FY ended 31st March, 2026
  • New Date: Tuesday, 29th September, 2026 (previously Wednesday, 23rd September, 2026)
  • Mode: Video Conferencing (VC) / Other Audio-Visual Means (OAVM)
  • Compliance: Conducted in accordance with MCA and SEBI circulars

2. Book Closure

  • Purpose: For determining members eligible to attend the 38th AGM
  • Period: Wednesday, 23rd September, 2026 to Tuesday, 29th September, 2026 (both days inclusive)
  • Documents Affected: Register of Members and Share Transfer Books

3. Record Date for Dividend

  • New Record Date: Tuesday, 22nd September, 2026 (previously Wednesday, 16th September, 2026)
  • Purpose: Determining members eligible to receive dividend for financial year 2025-26
  • Condition: Subject to approval at the ensuing AGM
  • Payment Timeline: To be paid within stipulated time period after approval

Additional Information

  • All other items from the previous intimation dated 31st July, 2026 remain unchanged
  • The communication is addressed to both BSE Limited and National Stock Exchange of India Ltd.
  • Signed by Thirumalesh Tumma, Company Secretary, on behalf of SMS Pharmaceuticals Limited